Author: Alec Sherman

Dive deep with David Drapkin, LCSW as he explores the nuances of the budding world of psychedelic therapy.

• Discover the Resurgence: Get an intimate look into the burgeoning field of psychedelic therapy and the transformative potentials it holds. An age-old wisdom is now weaving its way into modern therapeutic techniques, and while it can be nerve-wracking to take the plunge, it’s equally as exciting.

• Chart Your Own Path: Curious about carving out a niche for yourself in this arena? We’ll demystify the various career trajectories that beckon. Whether you’re a seasoned professional or someone just stepping in, there’s a space for everyone.

• Navigating the Tape: The world of psychedelics is as intricate legally as it is mentally. Dive into an exploration of the legal and regulatory terrains that shape this groundbreaking therapy.

Are you looking to level up your offerings in the expanding field of psychedelic-assisted support and want to know how to get there?

Are you considering attending our upcoming cohort of Vital, our 12-month psychedelic training certificate program?

If so, do you have questions before applying?

You’re in the right place! We will be hosting live presentations & Q&A’s to answer all of your questions to help you feel prepared to sign up for our upcoming course.

More Q&A sessions will be announced soon!

To register, please click on the links below :

Thursday September 28th, 1 — 2 PM EST: Introduction to Psychedelic Therapy and Career Pathways

Wednesday October 11th, 2 — 3 PM EST

Wednesday November 8th, 2 – 3 PM EST

Join David Drapkin and Angie Leek on a one-of-a-kind LinkedIn Live to discuss the current available options in a psychedelic practitioner’s toolkit & the importance of a transpersonal framework in working with hard-to-beat mental health conditions.

Are you interested in enrolling our live Navigating Psychedelics course?

Do you have questions about our curriculum or robust slate of masterclasses?

Are you looking to level up your offerings in the expanding field of psychedelic-assisted support and want to know how to get there?

Join lead instructor David Drapkin in a live session to learn more about our program and connect with him personally on any matters at all!

On November 1, the Oregon Health Authority published its proposed final rules for the Measure 109 psilocybin services program. OHA also has given “last call” for public comment and scheduled three public comment hearings November 15-17.

Join attorney and activist Jon Dennis in a conversation moderated by Professor Pilar Hernandez Wolf about the proposed psilocybin rules and ways to help educate OHA around issues of community concern.

During this webinar, Aaron will provide a very brief introduction to the intersection of psychedelics & autism. He and the audience will then dive into an open Q&A with space for individuals to briefly share about their own experiences, if they feel called to do so.

Aaron Paul Orsini is an autistic psychedelic author, researcher, educator & community organizer. In addition to publishing three books on his area of focus — Autism On Acid (2019), Autistic Psychedelic (2021), & Intro To Psychedelic Autism (2022) — Aaron also serves as the Outreach & Education Director of the AutisticPsychedelic.com Community (APC), a collaborative online org offering resource libraries, public chat forums, weekly peer support Zoom meetings, & online education courses for autistic adults & the therapists, guides, clinicians & family members who seek to support them through psychedelic-informed care.

Aaron also serves as an advisory co-author partner to psychedelic autism researchers at University College London, where he & his fellow researchers are soon to publish the world’s first peer-reviewed survey examining outcomes in naturalistic psychedelic use among autistic adults. The survey is scheduled to be released via open access early next year.

For more information about the APC, please visit AutisticPsychedelic.com, & for more information on other initiatives that Aaron is involved in, please visit: http://linktr.ee/aaronorsini

Please note that registrations (names, email addresses) are shared with the webinar collaborator.

When it comes to patient populations, veterans are among the most challenging to treat. Many return from service with debilitating conditions, including PTSD, treatment resistant depression, traumatic brain injury and chronic pain.

The costs – both financial and human – of military service are extreme. Recent studies suggest that between 2001 and 2050, the total costs of caring for veterans of the post-9/11 wars will reach between $2.2 and $2.5 trillion. It is estimated that on average, 44 veterans die in the United States every day from suicide.

Can psychedelics promise new hope to veterans suffering in sub-standard models of care? How can psychedelics be used to create a better standard of care for veterans and their families?

Join us in discussion with three North American veterans (Arron Victory, Apex Labs; Jesse Gould, Heroic Hearts; and Justin LaPree, Heroic Path to Light) on the eve of Remembrance Day (Canada) and Veterans Day (U.S.) on topics including:

• How psychedelics are currently being used by veteran populations, both above and underground
• The current standard of care for veterans post-service, the strengths of the current system and where it falls short
• Grassroots community efforts to support veterans and first responders in North America
• How biotech is working to create alternate psychedelic treatment options for veteran populations
• Ongoing and upcoming clinical trials to study the effects of psychedelics on veterans
• How governments are responding to calls for psychedelic access for veterans
• Successes veterans and their families are finding in psychedelic therapies

A growing number of mental health professionals are enrolling in training programs in psychedelic-assisted psychotherapy, but don’t know know to implement PAP in their practice. Join cofounder and CEO Jonathan Sabbagh to learn more about how Journey Clinical enables licensed psychotherapists to deliver PAP in your own practice, starting with Ketamine-Assisted Psychotherapy. Jonathan will explain the Journey Clinical collaborative care model and technology platform, and share how their member psychotherapists successfully deliver KAP in their practice as an adjunct to therapy.

Jonathan is the Co-Founder and CEO of Journey Clinical, the leading telehealth platform expanding access to Psychedelic-Assisted Psychotherapy. A serial entrepreneur, Jonathan built his career in finance, spending over two decades working for hedge funds and building businesses in Switzerland and NYC. After receiving a difficult diagnosis of PTSD and extreme burnout, Jonathan left the world of finance to focus on his mental health, during which he personally experienced the transformative benefits of plant medicine and Ketamine-Assisted Psychotherapy (KAP).

Ultimately, Jonathan’s personal and professional journey motivated him to found Journey Clinical in 2020, the #1 platform in the US that enables licensed mental health professionals to deliver KAP at scale. Learn more at www.JourneyClinical.com.

Please note that registrations (names, email addresses) are shared with the webinar collaborator.

Join us for “Traditional and Modern Perspectives on Healing,” part two of a two-part series in collaboration with the Indigenous Medicine Conservation Fund (IMC Fund). The IMC Fund was co-created for the sovereign protection and regeneration of the medicines, ecologies & traditional knowledge Indigenous communities have honored for thousands of years.

In this webinar, we will be looking at the importance of respecting traditional Indigenous cultures and practices. This panel brings together professionals with both traditional and modern training to discuss these medicines and how they are being worked with at this time by different groups and in different demographics, and to learn together in an exchange between equals. Building on part one of the series, panelists will discuss the differences between appreciation and appropriation, and share their experience in the field and on the ground.

Please note that registrations (names, email addresses) are shared with the webinar collaborator.